论文部分内容阅读
心电安即原儿茶酸(Protocatchnic acid),经南京医学院药理教研组动物试验表明具有减少心肌氧耗量,延长心肌耐缺氧时间,而增加冠脉血流作用较弱。我院1977年8月至1979年2月,对心电安治疗冠心病60例进行了观察,其结果如下。用法:心电安为南通制药厂生产,口服每次400毫克,一日三次,8周为一疗程。病例选择与分型:按1973年全国冠心病座谈会标准,除有心绞痛等典型症状外并治疗前后作平静心电图或二级梯运动试验,超声心动图,眼底,血脂,胸透等检查。其中属Ⅰ型(隐性冠心病)8例,Ⅱ型(不典型心绞痛)13例,Ⅲ型(典型心绞痛)34例,Ⅳ型(心绞痛伴心衰或心律紊乱)5例。
Electrocardiogram that protocatechuic acid (Protocatchnic acid), Nanjing Medical College Pharmacology Teaching and Research Group animal experiments have shown to reduce myocardial oxygen consumption, prolong myocardial hypoxia time, and increase coronary blood flow weaker. Our hospital from August 1977 to February 1979, ECG treatment of coronary heart disease in 60 cases were observed, the results are as follows. Usage: ECG for Nantong pharmaceutical factory production, 400 mg orally each time, three times a day, 8 weeks for a course of treatment. Case selection and typing: according to the 1973 National Coronary Heart Disease Symposium standards, except for the typical symptoms such as angina and before and after treatment for tranquil ECG or secondary lift exercise test, echocardiography, fundus, blood lipids, chest X-ray examination. Among them, there were 8 cases of type Ⅰ (recessive coronary heart disease), 13 cases of type Ⅱ (atypical angina pectoris), 34 cases of type Ⅲ (typical angina pectoris) and 5 cases of type Ⅳ (angina pectoris with heart failure or heart rhythm disorder).